U.S. government’s first look at the real-world use of the mRNA type of COVID-19 vaccines found their effectiveness was nearly as robust as it was in controlled studies.
ADVERTISEMENT
ADVERTISEMENT
U.S. government’s first look at the real-world use of the mRNA type of COVID-19 vaccines found their effectiveness was nearly as robust as it was in controlled studies.